Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 9:30 pm Sale | 2024-12-04 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital Management LLC | 2,548,905 5.000% | -1,522,949 (-37.40%) | Filing History |
| 2024-11-19 9:31 pm Sale | 2024-11-15 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital Management LLC | 4,071,854 7.700% | -914,461 (-18.34%) | Filing History |
| 2024-11-19 09:57 am Unchanged | 2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital Management LLC | 1,020,052 2.800% | 0 (Unchanged) | Filing History |
| 2024-11-18 9:57 pm Purchase | 2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital Management LLC | 1,020,052 2.800% | 1,020,052 (New Position) | Filing History |
| 2024-11-07 9:35 pm Unchanged | 2024-11-06 | 13D | Tango Therapeutics, Inc. TNGX | Boxer Capital Management LLC | 6,988,450 6.500% | 0 (Unchanged) | Filing History |
| 2024-10-28 09:22 am Purchase | 2024-10-25 | 13D | Tango Therapeutics, Inc. TNGX | Boxer Capital Management LLC | 6,988,450 6.500% | 6,988,450 (New Position) | Filing History |
| 2024-10-25 9:48 pm Purchase | 2024-10-10 | 13G | uniQure N.V. QURE | Boxer Capital Management LLC | 2,225,000 4.600% | 2,225,000 (New Position) | Filing History |
| 2024-10-25 9:46 pm Purchase | 2024-10-10 | 13G | SpringWorks Therapeutics, Inc. SWTX | Boxer Capital Management LLC | 3,421,541 4.600% | 3,421,541 (New Position) | Filing History |
| 2024-10-25 9:44 pm Purchase | 2024-10-10 | 13G | Nkarta, Inc. NKTX | Boxer Capital Management LLC | 3,443,606 4.900% | 3,443,606 (New Position) | Filing History |
| 2024-10-25 9:42 pm Purchase | 2024-10-10 | 13G | Instil Bio, Inc. TIL | Boxer Capital Management LLC | 355,500 5.500% | 355,500 (New Position) | Filing History |
| 2024-10-25 9:39 pm Purchase | 2024-10-10 | 13G | Century Therapeutics, Inc. IPSC | Boxer Capital Management LLC | 3,174,603 3.700% | 3,174,603 (New Position) | Filing History |
| 2024-10-25 9:37 pm Purchase | 2024-10-10 | 13G | Fate Therapeutics, Inc. FATE | Boxer Capital Management LLC | 4,960,910 4.400% | 4,960,910 (New Position) | Filing History |
| 2024-10-22 9:15 pm Purchase | 2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital Management LLC | 4,986,315 9.900% | 4,986,315 (New Position) | Filing History |